Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer's disease and reverting to normal cognition

Journal of the Neurological Sciences

Volumn 346, Issue 1-2, 2014, Pages 288-292

  Tokuchi, Ryo ^a   Hishikawa, Nozomi ^a   Kurata, Tomoko ^b   Sato, Kota ^a   Kono, Syoichiro ^a   Yamashita, Toru ^a   Deguchi, Kentaro ^a   Abe, Koji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Uohashi Hospital   (Japan)

Author keywords

Alzheimer's disease; Clinical and demographic predictors; Converter; Mild cognitive impairment; Reverter

Indexed keywords

ACADEMIC ACHIEVEMENT; ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; CLINICAL FEATURE; COGNITION; DEMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAHIPPOCAMPAL GYRUS ATROPHY; PREDICTION; RISK FACTOR; SCORING SYSTEM; SEX DIFFERENCE; VASCULAR RISK FACTOR; VOXEL BASED MORPHOMETRY; VOXEL BASED SPECIFIC REGIONAL ANALYSIS SYSTEM FOR ALZHEIMER DISEASE; WHITE MATTER LESION; ATROPHY; BRAIN; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ATROPHY; BRAIN; COGNITION; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84910128743     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2014.09.012     Document Type: Article

References (35)

1. R.C. Petersen, G.E. Smith, S.C. Waring, R.J. Ivnik, E.G. Tangalos, and E. Kokmen Mild cognitive impairment: clinical characterization and outcome Arch Neurol 56 1999 303 308 10.1001/archneur.56.3.303
2. S. Larrieu, L. Letenneur, and J.M. Orgogozo Incidence and outcome of mild cognitive impairment in a population-based prospective cohort Neurology 59 2002 1594 1599 10.1212/01.WNL.0000034176.07159
3. L. Rozzini, B.V. Chilovi, and M. Conti Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration Int J Geriatr Psychiatry 22 2007 1217 1222 10.1002/gps.1816
4. T.D. Koepsell, and S.E. Monsell Reversion from mild cognitive impairment to normal or near-normal cognition: risk factors and prognosis Neurology 79 2012 1591 1598 10.1212/WNL.0b013e31826e26b7
5. R.C. Petersen, P.S. Aisen, and L.A. Beckett Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization Neurology 74 2010 201 209 10.1212/WNL.0b013e3181cb3e25
6. M. Ganguli, B.E. Snitz, and J.A. Saxton Outcomes of mild cognitive impairment by definition: a population study Arch Neurol 68 2011 761 767 10.1001/archneurol.2011.101
7. P.S. Sachdev, D.M. Lipnicki, and J. Crawford Factors predicting reversion from mild cognitive impairment to normal cognitive functioning: a population-based study PLoS One 8 2013 e59649 10.1371/journal.pone.0059649
8. F. Maioli, M. Coveri, and P. Pagni Conversion of mild cognitive impairment to dementia in elderly subjects: a preliminary study in a memory and cognitive disorder unit Arch Gerontol Geriatr 44 2007 233 241 10.1016/j.archger.2007.01.032
9. S.M. Landau, D. Harvey, and C.M. Madison Comparing predictors of conversion and decline in mild cognitive impairment Neurology 75 2010 230 238 10.1212/WNL.0b013e3181e8e8b8
10. J. Li, Y.J. Wang, and M. Zhang Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease Neurology 76 2011 1485 1491 10.1212/WNL.0b013e318217e7a4
11. R.O. Roberts, D.S. Knopman, and M.M. Mielke Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal Neurology 82 2014 1 9 10.1212/WNL.0000000000000055
12. R.C. Petersen, R.O. Roberts, and D.S. Knopman Mild cognitive impairment: ten years later Arch Neurol 66 2009 1447 1455 10.1001/archneurol.2009.266
13. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1984 939 944 [ http://www.neurology.org/ ]
14. Y. Hirata, H. Matsuda, and K. Nemoto Voxel-based morphometry to discriminate early Alzheimer's disease from controls Neurosci Lett 382 2005 269 274 10.1016/j.neulet.2005.03.038
15. F. Fazekas, J.B. Chawluk, A. Alavi, H.I. Hurtig, and R.A. Zimmerman MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging AJR Am J Roentgenol 149 1987 351 356 10.2214/ajr.149.2.351
16. Y. Kanda Investigation of the freely-available easy-to-use software "EZR" (Easy R) for medical statistics Bone Marrow Transplant 48 2013 452 458 10.1038/bmt.2012.244
17. G. Xu, J.S. Meyer, J. Thornby, M. Chowdhury, and M. Quach Screening for mild cognitive impairment (MCI) utilizing combined mini-mental-cognitive capacity examinations for identifying dementia prodromes Int J Geriatr Psychiatry 17 2002 1027 1033 10.1002/gps.744
18. K. Abe, Y. Ikeda, and T. Kurata Cognitive and affective impairments of a novel SCA/MND crossroad mutation Asidan Eur J Neurol 19 2012 1070 1078 10.1111/j.1468-1331.2012.03669.x
19. H. Xie, N. Mayo, and L. Koski Predictors of future cognitive decline in persons with mild cognitive impairment Dement Geriatr Cogn Disord 32 2011 308 317 10.1159/000334996
20. R. Gallassi, F. Oppi, and R. Poda Are subjective cognitive complaints a risk factor for dementia? Neurol Sci 31 2010 327 336 10.1007/s10072-010-0224-6
21. M. Mauri, E. Sinforiani, C. Zucchella, M.G. Cuzzoni, and G. Bono Progression to dementia in a population with amnestic mild cognitive impairment: clinical variables associated with conversion Funct Neurol 27 2012 49 54 [ http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3812753/ ]
22. J. Lindsay, D. Laurin, and R. Verreault Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging Am J Epidemiol 156 2002 445 453 10.1093/aje/kwf074
23. L. Bracco, C. Piccini, and M. Moretti Alzheimer's disease: role of size and location of white matter changes in determining cognitive deficits Dement Geriatr Cogn Disord 20 2005 358 366 10.1159/000088562
24. J.M. Burns, J.A. Church, and D.K. Johnson White matter lesions are prevalent but differentially related with cognition in aging and early Alzheimer disease Arch Neurol 62 2005 1870 1876 10.1001/archneur.62.12.1870
25. N. Hirono, H. Kitagaki, H. Kazui, M. Hashimoto, and E. Mori Impact of white matter changes on clinical manifestation of Alzheimer's disease: A quantitative study Stroke 31 2000 2182 2188 10.1161/01.STR.31.9.2182
26. I. Kono, S. Mori, and K. Nakajima Do white matter changes have clinical significance in Alzheimer's disease? Gerontology 50 2004 242 246 10.1159/000078353
27. J.C. de la Torre Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics Lancet Neurol 3 2004 184 190 10.1016/S1474-4422(04)00683-0
28. Y. Deschaintre, F. Richard, D. Leys, and F. Pasquier Treatment of vascular risk factors is associated with slower decline in Alzheimer disease Neurology 73 2009 674 680 10.1212/WNL.0b013e3181b59bf3
29. V. Solfrizzi, F. Panza, and A.M. Colacicco Vascular risk factors, incidence of MCI, and rates of progression to dementia Neurology 63 2004 1882 1891 [ http://www.neurology.org/ ]
30. X.F. Meng, J.T. Yu, and H.F. Wang Midlife vascular risk factors and the risk of Alzheimer's disease: a systematic review and meta-analysis J Alzheimers Dis 2014 10.3233/JAD-140954 [Epub ahead of print]
31. C.R. Jack Jr., M.M. Shiung, and J.L. Gunter Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD Neurology 62 2004 591 600 10.1212/01.WNL.0000110315.26026.EF
32. S.S. Staekenborg, E.L. Koedam, and W.J. Henneman Progression of mild cognitive impairment to dementia: contribution of cerebrovascular disease compared with medial temporal lobe atrophy Stroke 40 2009 1269 1274 10.1161/STROKEAHA.108.531343
33. Y.S. Shim, Y.C. Youn, and D.L. Na Effects of medial temporal atrophy and white matter hyperintensities on the cognitive functions in patients with Alzheimer's disease Eur Neurol 66 2011 75 82 10.1159/000329277
34. R. Tokuchi, K. Deguchi, T. Yamashita, and K. Abe Impact of combined medial temporal atrophy and white matter lesion for cognitive function and emotional function in Alzheimer's disease patients Nihon Ronen Igakkai Zasshi 51 2014 342 349
35. T. Nickl-Jockschat, A. Kleiman, and J.B. Schulz Neuroanatomic changes and their association with cognitive decline in mild cognitive impairment: a meta-analysis Brain Struct Funct 217 2012 115 125 10.1007/s00429-011-0333-x